Personalized phenotypic ex vivo drug sensitivity platform identifies frequent HDAC inhibitor-based combination sensitivities in T-cell lymphomas.

被引：0
|
作者：
Goh, Jasmine Ya Hwee [1 ]
De Mel, Sanjay [2 ]
Rashid, Masturah [3 ]
Jeyasekharan, Anand [2 ]
Chow, Edward Kai-Hua [1 ]
机构：
[1] Natl Univ Singapore, Singapore, Singapore
[2] Natl Univ Canc Inst, Singapore, Singapore
[3] KYAN Therapeut, Singapore, Singapore
来源：
CANCER RESEARCH | 2022年 / 82卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B023
引用
收藏
页数：2
相关论文
共 6 条
  • [1] An Ex-Vivo Combination Drug Sensitivity Platform for Predicting Sensitivity to FLT3 Inhibitor-Based Combination in Acute Myeloid Leukemia
    Sahib, Noor Rashidha Binte Meera
    Ying, Jen Wei
    Ooi, Melissa
    Chee, Yen Lin
    Rashid, Masturah
    Jayalakshmi, Jayalakshmi
    Chow, Edward K. H.
    [J]. BLOOD, 2022, 140 : 7840 - 7841
  • [2] AN EX-VIVO COMBINATION DRUG SENSITIVITY PLATFORM FOR PREDICTING SENSITIVITY TO FLT3 INHIBITOR-BASED COMBINATION IN ACUTE MYELOID LEUKEMIA
    Sahib, Noor Rashidha Bte Meera
    Ying, Jen Wei
    Ooi, Melissa
    Chee, Yen Lin
    Jayalakshmi
    Mohamed, Jameelah Bte Sheik
    Rashid, Masturah
    Chow, Edward K. H.
    [J]. CANCER RESEARCH, 2024, 84 (08)
  • [3] Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
    Omar Khan
    Nicholas B La Thangue
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 714 - 726
  • [4] Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
    Khan, Omar
    La Thangue, Nicholas B.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 714 - 726
  • [5] Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
    de Mel, Sanjay
    Rashid, Masturah B. M.
    Zhang, Xi Yun
    Goh, Jasmine
    Lee, Chun Tsu
    Poon, Li Mei
    Chan, Esther H. L.
    Liu, Xin
    Chng, Wee Joo
    Chee, Yen Lin
    Lee, Joanne
    Yuen, Yi Ching
    Lim, Jing Quan
    Chia, Burton K. H.
    Laurensia, Yurike
    Huang, DaChuan
    Pang, Wan Lu
    Cheah, Daryl Ming Zhe
    Wong, Esther Kam Yin
    Ong, Choon Kiat
    Tang, Tiffany
    Lim, Soon Thye
    Ng, Siok Bian
    Tan, Soo Yong
    Loi, Hoi-Yin
    Tan, Lip Kun
    Chow, Edward K.
    Jeyasekharan, Anand D.
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [6] Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
    Sanjay de Mel
    Masturah B. M. Rashid
    Xi Yun Zhang
    Jasmine Goh
    Chun Tsu Lee
    Li Mei Poon
    Esther H. L. Chan
    Xin Liu
    Wee Joo Chng
    Yen Lin Chee
    Joanne Lee
    Yi Ching Yuen
    Jing Quan Lim
    Burton K. H. Chia
    Yurike Laurensia
    DaChuan Huang
    Wan Lu Pang
    Daryl Ming Zhe Cheah
    Esther Kam Yin Wong
    Choon Kiat Ong
    Tiffany Tang
    Soon Thye Lim
    Siok Bian Ng
    Soo Yong Tan
    Hoi-Yin Loi
    Lip Kun Tan
    Edward K. Chow
    Anand D. Jeyasekharan
    [J]. Blood Cancer Journal, 10
1